GLP-1 Drug Liraglutide Prevents Lupus-Associated Lung Hemorrhage in Mouse Model | Research

The takeaway

Liraglutide prevented lupus-associated diffuse alveolar hemorrhage by inhibiting inflammatory signaling pathways, demonstrating GLP-1 drug repurposing for autoimmune lung complications.

Lupus lungs protected
A widely available diabetes drug prevented the life-threatening lung hemorrhage complication of lupus in a mouse model

What the researchers found

Liraglutide prevented lupus-associated DAH in a mouse model by inhibiting inflammatory signaling pathways, demonstrating novel autoimmune lung protection by a GLP-1 RA.

Why it matters

Lupus DAH is often fatal with few treatments. A widely available GLP-1 drug could save lives if confirmed in human studies.

How the study worked

Lupus-associated DAH mouse model treated with liraglutide, with assessment of lung hemorrhage, inflammatory pathway analysis, and mechanistic characterization.

What this study cannot tell us

Mouse model. Lupus is complex — mouse models don't fully replicate human disease. Prevention vs treatment distinction important.

How to read the evidence

Preclinical mouse model. Important proof-of-concept for novel GLP-1 autoimmune indication.

When this study was published

Published in 2025.

The bigger picture

GLP-1 drugs'anti-inflammatory properties extend to autoimmune lung disease — expanding their therapeutic potential beyond metabolism.

Questions still open

Would liraglutide help human lupus DAH patients?
Should lupus patients on GLP-1 drugs be monitored for reduced DAH risk?
Could GLP-1 drugs treat other lupus complications?

Common questions

Can GLP-1 drugs help lupus?

In mice, liraglutide prevented a dangerous lupus lung complication (diffuse alveolar hemorrhage) by suppressing inflammation. Human studies are needed to confirm this benefit.

Why would a diabetes drug help autoimmune disease?

GLP-1 drugs have powerful anti-inflammatory properties that extend far beyond blood sugar control. These effects may suppress the autoimmune inflammation driving lupus complications.

Read the original research

Liraglutide prevents lupus-associated diffuse alveolar hemorrhage via inhibiting lymphocyte infiltration and promoting macrophage M2 polarization.

Journal of translational autoimmunity, 12, 100349

View on PubMed ↗Publisher’s paper ↗

Citation

Jiang, Li; He, Liting; Li, Duo; Luo, Xin; Yang, Ming; Wu, Haijing; Long, Hai. (2026). Liraglutide prevents lupus-associated diffuse alveolar hemorrhage via inhibiting lymphocyte infiltration and promoting macrophage M2 polarization.. Journal of translational autoimmunity, 12, 100349. https://doi.org/10.1016/j.jtauto.2026.100349